Home » Topics » Regulatory

Regulatory
RSS

Protonix delayed-release tablets approved for long-term treatment of Zollinger-Ellison syndrome

May 7, 2002

Generex completes proof-of-concept study for buccal fentanyl citrate

May 6, 2002

Sheffield and Inhale to develop inhaled migraine therapy

May 6, 2002

Zomig RM approved in Japan

May 3, 2002

Orphan Medical licenses rights to butamben

April 29, 2002

Faslodex approved in U.S. for tamoxifen-resistant breast cancer

April 29, 2002

MediGene submits MAA in Germany for Eligard 22.5 mg

April 26, 2002

Periostat approved in Austria and Finland

April 26, 2002

Prefilled syringe presentation of Copaxone launched

April 26, 2002

Xalatan approved in E.U. as first-line therapy for lowering IOP in glaucoma patients

April 24, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
New evidence links autoimmunity to long COVID symptoms
BioWorld
Recent findings are reshaping current understanding of the post-infection landscape of SARS-CoV-2. Although previous studies had already suggested that...
BMS-Hengrui deal strikes panic in Washington
BioWorld
On the heels of the multibillion-dollar licensing deal between Bristol Myers Squibb Co. and Jiangsu Hengrui Pharmaceuticals Co. Ltd., Chairman John Moolenaar...
Initial data hint that US MFN pricing is hitting access in Europe
BioWorld
There are initial signs that President Donald Trump’s most-favored nation (MFN) policy may be further delaying access to new drugs in Europe, as companies hold...